AdBio is a Paris-based venture capital firm backing early-stage life sciences companies across Europe, with a focus on biotechnology, therapeutics and pharmaceutical innovation. It works with scientific founders and academic institutions on company building, with portfolio themes including oncology, immunology, ophthalmology and rare diseases, and has also participated in later-stage follow-on financings.